Zoom's share price plummets following COVID vaccine news

Tom Wright
clock • 1 min read
Zoom's share price plummets following COVID vaccine news

Zoom's share price drops 17 per cent

Zoom's share price dropped as much as 17 per cent today following news that a COVID vaccine has proved effective in trials. Preliminary analysis shows that a vaccine developed by US firm Pfizer and German partner BioNTech can stop 90 per cent of people catching the coronavirus, based on a study with 43,000 participants. Stock markets around the world climbed after the news was published by Pfizer, with the FTSE 100 up six per cent, and Wall Street's S&P 500 index  up four per cent ahead...

To continue reading this article...

Join Channel Partner Insight

  • Exclusive news, insight and analysis for the IT channel across the US and Europe
  • Gain the latest insights through market analysis and interviews with channel leaders
  • Stay on top of key trends with an exclusive members-only podcast
  • Breaking news stories delivered straight to your inbox daily

Join now

 

Already a member?

Log in

More on Distribution

US vendor IRONSCALES lands deal with UK VAD Distology to offer email security across EMEA

US vendor IRONSCALES lands deal with UK VAD Distology to offer email security across EMEA

The email security specialist provides awareness training for IT leaders to help flag phishing attacks

Kelsey Rees
clock 16 August 2022 • 2 min read
Switzerland's ALSO Group announces €100m share buyback program

Switzerland's ALSO Group announces €100m share buyback program

The group’s CEO claims the share is currently undervalued

Kelsey Rees
clock 10 August 2022 • 1 min read
Component sales lifts Arrow to 'all-time record quarter' in Q2

Component sales lifts Arrow to 'all-time record quarter' in Q2

The distributor saw both component and enterprise solutions sales rise in Europe, while the latter stagnated in the Americas

Kelsey Rees
clock 09 August 2022 • 2 min read